@Racer88 stated “In 2012 and 2016, mRNA
COVID-SARS vaccine trials included challenge testing. In 100% of the (animal) subjects, ADE (antibody dependent enhancement) was observed. Accordingly, those trials were terminated.”
I believe
@Racer88 is referring to SARS-COVID-1.
SARS-COVID-1 officially was identified in 2002 and died off on it‘s in 2004.
MERS-COV (Middle Eastern Respiratory Syndrome) 2012-2014.
SARS-COV-2 is from 2019 forward.
None or the drug companies/medical research centers/governments were ever able to develop a vaccine for SARS-COV-1 deploying multiple vaccine technologies all the way thru 2016. I’ll see if I can fInd various articles I saved on the history of it and link them.
No vaccine ever developed for MERS-COV either.
I don’t remember reading any prior articles/research docs on vaccine trials using MRNA technologies for SARS-COVID-1. Not saying it didn’t happen just don‘t recall.
Either way it’s interesting to note that from my recollection, after decades of research not one entity was able to develop a vaccine for SARS-COV-1 nor MERS-COV yet they developed a SARS-COV-2 in 6 months with limited human safety trials. Plus Moderna and Pfizer were given legal waivers against being sued and are protected from product liability regarding the COVID-19 vaccines.